Skip to main content
Clinical Trials/CTRI/2026/03/106311
CTRI/2026/03/106311Not yet recruitingNot Applicable

Comparison of Patient Perceptions and Practitioner Preferences in Guided Biofilm Therapy Versus Ultrasonic Piezo Scaling: A Randomized Controlled Trial

GSL DENTAL COLLEGE AND HOSPITAL1 site in 1 country30 target enrollmentStarted: May 1, 2026Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
Plaque index and questionnaires assessing comfort, pain, sensitivity, efficiency, and satisfaction levels ranges from 0-10 after treatment

Study Overview

Brief Summary

Periodontal diseases, primarily caused by microbial biofilm, remain one of the most prevalent oral health problems and a major reason for tooth loss in adults. Although conventional scaling and root planing (SRP) with hand and ultrasonic instruments has long been considered the gold standard for biofilm removal, it is often time-consuming. technique-sensitive, and associated with adverse effects such as cementum loss. postoperative sensitivity, and considerable patient discomfort. These limitations highlight the need for less invasive, more efficient, and patient-friendly alternatives. Guided Biofilm Therapy (GBT), which integrates air-polishing with ultrasonic instrumentation, offers a systematic and minimally invasive approach that may reduce treatment time, enhance patient comfort, and improve clinical efficiency while maintaining therapeutic effectiveness. Therefore, it is necessary to evaluate and compare GBT with conventional scaling to determine its clinical relevance, patient acceptance, and practitioner preference.

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
Participant Blinded

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Participants eligible for the study were adults aged 18 to 60 years with a minimum of 20 natural teeth.
  • The teeth included in the study were required to be free from dental caries, abrasion, erosion, or any other structural defects.
  • Only systemically healthy individuals diagnosed with Stage I or Stage II periodontitis were included.
  • Additionally, participants were required to have no caries or abrasions present in the teeth selected for evaluation.

Exclusion Criteria

  • The exclusion criteria included individuals with systemic diseases such as diabetes, heart disease, or cancer, and those suffering from respiratory diseases including chronic obstructive pulmonary disease or asthma.
  • Participants who had used antibiotics within three months prior to the start of the study were also excluded.
  • In addition, pregnant or lactating women, individuals with a known allergy to chlorhexidine or erythritol, and smokers consuming more than 10 cigarettes per day were not eligible for inclusion.
  • Furthermore, individuals who were unwilling to undergo the proposed treatment were excluded from the study.

Outcomes

Primary Outcomes

Plaque index and questionnaires assessing comfort, pain, sensitivity, efficiency, and satisfaction levels ranges from 0-10 after treatment

Time Frame: BASELINE

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
GSL DENTAL COLLEGE AND HOSPITAL
Sponsor Class
Other [PRIVATE DENTAL COLLEGE]
Responsible Party
Principal Investigator
Principal Investigator

Dr Kata Sai Sruthi

GSL DENTAL COLLEGE AND HOSPITAL

Study Sites (1)

Loading locations...

Similar Trials